GW&K Investment Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.4M Sell
88,313
-97
-0.1% -$14.7K 0.12% 238
2025
Q1
$13.3M Buy
88,410
+25,744
+41% +$3.87M 0.12% 238
2024
Q4
$11.6M Buy
62,666
+2,953
+5% +$545K 0.1% 254
2024
Q3
$11.8M Buy
59,713
+1,051
+2% +$207K 0.1% 245
2024
Q2
$12.1M Buy
58,662
+4,001
+7% +$827K 0.11% 241
2024
Q1
$14.8M Sell
54,661
-849
-2% -$230K 0.13% 213
2023
Q4
$13.1M Buy
55,510
+9,782
+21% +$2.31M 0.12% 224
2023
Q3
$8.96M Buy
45,728
+16,790
+58% +$3.29M 0.09% 244
2023
Q2
$6.08M Buy
28,938
+1,000
+4% +$210K 0.06% 260
2023
Q1
$5.64M Buy
27,938
+3,744
+15% +$756K 0.05% 260
2022
Q4
$5.27M Buy
24,194
+13,852
+134% +$3.02M 0.05% 258
2022
Q3
$2.04M Sell
10,342
-489
-5% -$96.2K 0.02% 302
2022
Q2
$2.32M Sell
10,831
-495
-4% -$106K 0.03% 296
2022
Q1
$3.22M Sell
11,326
-266
-2% -$75.5K 0.03% 290
2021
Q4
$4.37M Sell
11,592
-3,710
-24% -$1.4M 0.04% 274
2021
Q3
$6.32M Sell
15,302
-75
-0.5% -$31K 0.06% 244
2021
Q2
$5.69M Sell
15,377
-8,925
-37% -$3.3M 0.05% 264
2021
Q1
$7.04M Sell
24,302
-3,715
-13% -$1.08M 0.06% 240
2020
Q4
$7M Sell
28,017
-10,620
-27% -$2.65M 0.07% 239
2020
Q3
$8.75M Sell
38,637
-2,050
-5% -$464K 0.11% 217
2020
Q2
$7.09M Buy
40,687
+2,800
+7% +$488K 0.1% 219
2020
Q1
$4.78M Sell
37,887
-8,025
-17% -$1.01M 0.08% 219
2019
Q4
$7.01M Sell
45,912
-3,030
-6% -$463K 0.09% 223
2019
Q3
$6.48M Sell
48,942
-2,585
-5% -$342K 0.09% 218
2019
Q2
$7.31M Buy
+51,527
New +$7.31M 0.11% 217